申请人:Matsumoto Yoshiyuki
公开号:US20070032525A1
公开(公告)日:2007-02-08
The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C
1
-C
6
alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.
本发明提供了具有抑制CCR3配体结合到靶细胞CCR3的活性的低分子化合物,即CCR3拮抗剂。本发明还提供了由下式(I)表示的化合物,其药学上可接受的酸加合物或药学上可接受的C1-C6烷基加合物,以及包含它们作为有效成分的制药组合物,用于治疗或预防与CCR3相关的疾病,例如哮喘和过敏性鼻炎。